MeSH Terms
Antibodies, Monoclonal/therapeutic use
Antibodies, Monoclonal, Humanized
Antineoplastic Agents/adverse effects,therapeutic use
Antineoplastic Combined Chemotherapy Protocols/therapeutic use
Bevacizumab
Camptothecin/adverse effects,analogs & derivatives,therapeutic use
Capecitabine
Cetuximab
Chemotherapy, Adjuvant
Colorectal Neoplasms/drug therapy,surgery
Deoxycytidine/analogs & derivatives,therapeutic use
Fluorouracil/therapeutic use
Humans
Irinotecan
Organoplatinum Compounds/adverse effects,therapeutic use
Prodrugs/therapeutic use
Pyridines/adverse effects,therapeutic use
Chemicals
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antineoplastic Agents
Organoplatinum Compounds
Prodrugs
Pyridines
oxiplatin
Deoxycytidine
Bevacizumab
Capecitabine
Irinotecan
Cetuximab
Fluorouracil
Camptothecin
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Meyerhardt Jeffrey A
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
Mayer Robert J